The integration of real-world data into clinical research may mark a shift away from clinical trial information, said Viraj Narayanan, MBA, vice president of Life Sciences at COTA Healthcare.
The integration of real-world data into clinical research may mark a shift away from clinical trial information, said Viraj Narayanan, MBA, vice president of Life Sciences at COTA Healthcare.
Transcript
How has a growing understanding and acceptance of real-world data led to it being used more in clinical research?
When you think about the real world data movement, in the beginning of it, it really happened 5 or 6 years ago with the Affordable Care Act, where there was EMR adoption and it was forced on providers. You see this huge spike from, basically EMR adoption in the tens to the eighties in about 5 or 6 years. All this information, which used to be in a black box, is now digitized. The second main milestone was the Affordable Care Act, which essentially mandated for the first time that the federal government would consider alternatives to traditional clinical trial information, ie, real-world data. Since then, what is really driving adoption in consideration of real-world data is validation work, cross-industry validation work. So, I think about the last year and think about the Friends of Cancer research efforts that have that have come a long way. I think about Duke Margolis, and a lot of these policy stakeholders that are working with industry partners, with data companies, and sponsors, to define what are real world data endpoints. How do we consider this information in lieu of clinical trial information? Of course, the best way to advance the movement is examples. Probably the most exciting example this year was Pfizer's Ibrance being approved with no clinical trial information at all, exclusively using real world data. So, I think what we're going to see moving forward is continued applications and adoptions like Pfizer Ibrance as well as additional methodology work.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More